From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL).

about

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL).

Item

http://www.wikidata.org/entity/Q47895445

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

From Pathology to Precision Me ...... c Lymphoma Kinase (ALK+ ALCL).

@en

From Pathology to Precision Me ...... ing Anaplastic Lymphoma Kinase

@nl

type

Item

label

From Pathology to Precision Me ...... c Lymphoma Kinase (ALK+ ALCL).

@en

From Pathology to Precision Me ...... ing Anaplastic Lymphoma Kinase

@nl

prefLabel

From Pathology to Precision Me ...... c Lymphoma Kinase (ALK+ ALCL).

@en

From Pathology to Precision Me ...... ing Anaplastic Lymphoma Kinase

@nl

P1476

From Pathology to Precision Me ...... c Lymphoma Kinase (ALK+ ALCL).

@en

P2093

Mariusz A Wasik

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

Crizotinib in anaplastic large-cell lymphoma.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamy

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

P31

scholarly article

P356

10.3390/CANCERS9100138

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael T Werner

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29035291

http://www.w3.org/2001/XMLSchema#string

P932

5664077

http://www.w3.org/2001/XMLSchema#string